BridgeMD
Compares treatment options for Cancer
Official title Spiritual Care or Psychotherapy Versus Palliative Care Alone in Patients With Non-Curative Malignancies
ClinicalTrials.gov ID: NCT07290491
What this study is testing
- What it's testing
- This phase III clinical trial will evaluate the impact on survival of adding chaplain-provided spiritual care or psychotherapy/meditation to standard-of-care (SOC) and palliative measures, plus chemotherapy if recommended, and comparing it with SOC and palliative measures, plus chemotherapy if recommended, in patients with non-curative malignancies. The Palliative Care Department at Houston Methodist Hospital provides essential services to patients diagnosed with advanced cancer by sharing information and resources about symptom management, pain treatment and planning for the future.
- Phase 3: a large, late-stage study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients are eligible to be included in the trial only if all of the following criteria apply
- The patient provides written informed consent for the trial.
- Male or female ≥18 years of age on the day of informed consent signing.
- Histologically confirmed metastatic disease with life expectancy of one year or less.
- Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 3.
You likely can't join if
- Patients are excluded from the trial if any of the following criteria apply:
- Known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial. If a patient develops a...
- Mobility limitations that would interfere with cooperation with the requirements of the trial.
- Confirmed positive pregnancy test in women of child bearing potential.
See the full eligibility criteria
- Patients are eligible to be included in the trial only if all of the following criteria apply
- The patient provides written informed consent for the trial.
- Male or female ≥18 years of age on the day of informed consent signing.
- Histologically confirmed metastatic disease with life expectancy of one year or less.
- Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 3.
- Willing and able to comply with the protocol for the duration of the trial including undergoing scheduled visits and interventions.
- Patients are excluded from the trial if any of the following criteria apply:
- Known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial. If a patient develops a psychiatric disorder after baseline, he/she will not be taken off the...
- Mobility limitations that would interfere with cooperation with the requirements of the trial.
- Confirmed positive pregnancy test in women of child bearing potential.
The study team makes the final eligibility decision.
Where it's taking place
- Houston, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Houston, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.